Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy

GMP-consistent automatic synthesis of Lu-177 labelled DOTA-tate and the subsequent influence for stability

Stephan Maus, Erik de Blois, Mathias Schreckenberger and Wouter Breeman
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1383;
Stephan Maus
1Clinic and Polyclinic for Nuclear Medicine, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik de Blois
2Department of Nuclear Medicine, Erasmus MC, Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathias Schreckenberger
1Clinic and Polyclinic for Nuclear Medicine, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wouter Breeman
2Department of Nuclear Medicine, Erasmus MC, Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 54 no. supplement 2 1383

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2013

Author Information

  1. Stephan Maus1,
  2. Erik de Blois2,
  3. Mathias Schreckenberger1 and
  4. Wouter Breeman2
  1. 1Clinic and Polyclinic for Nuclear Medicine, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany
  2. 2Department of Nuclear Medicine, Erasmus MC, Rotterdam, Netherlands

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014100
Dec 2014100
Jan 2015100
Feb 2015100
May 2015100
Sep 2015900
Jan 2016100
Jul 2016500
Aug 2016400
Sep 2016700
Oct 2016300
Nov 2016400
Dec 2016500
Jan 20171000
Feb 2017900
Mar 2017700
Apr 2017700
May 2017900
Jun 2017100
Jul 2017600
Aug 2017600
Sep 2017100
Oct 2017400
Nov 2017600
Dec 2017200
Jan 2018300
Feb 2018200
Mar 2018200
Apr 2018100
May 20182500
Jun 2018300
Jul 2018500
Sep 2018200
Nov 2018300
Dec 2018300
Jan 2019200
Feb 2019100
Mar 2019900
Apr 2019600
May 2019600
Jun 2019100
Jul 2019400
Aug 2019300
Sep 2019600
Oct 2019200
Nov 2019800
Dec 2019500
Jan 2020600
Feb 20201700
Mar 20201300
Apr 2020700
May 2020500
Jun 2020500
Jul 2020300
Aug 2020400
Sep 2020200
Oct 2020400
Nov 20201100
Dec 2020800
Jan 20211600
Feb 2021900
Mar 20211500
Apr 20211900
May 2021900
Jun 20211100
Jul 2021700
Aug 2021900
Sep 2021900
Oct 20211300
Nov 20212300
Dec 2021900
Jan 2022900
Feb 2022800
Mar 20221300
Apr 20224400
May 20221400
Jun 2022500
Jul 20221300
Aug 2022700
Sep 20221200
Oct 2022900
Nov 2022900
Dec 2022500
Jan 20231000
Feb 2023800
Mar 20231300
Apr 20231000
May 20231400
Jun 20231700
Jul 20232000
Aug 20231000
Sep 2023900
Oct 20231700
Nov 20231300
Dec 2023700
Jan 20241400
Feb 20241700
Mar 2024400
Apr 2024700
May 20241100
Jun 20241000
Jul 20248700
Aug 20245400
Sep 20241200
Oct 20241600
Nov 20241400
Dec 2024500
Jan 20252200
Feb 20252100
Mar 20252700
Apr 20252800
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
GMP-consistent automatic synthesis of Lu-177 labelled DOTA-tate and the subsequent influence for stability
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
GMP-consistent automatic synthesis of Lu-177 labelled DOTA-tate and the subsequent influence for stability
Stephan Maus, Erik de Blois, Mathias Schreckenberger, Wouter Breeman
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1383;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
GMP-consistent automatic synthesis of Lu-177 labelled DOTA-tate and the subsequent influence for stability
Stephan Maus, Erik de Blois, Mathias Schreckenberger, Wouter Breeman
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1383;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy

  • Quantitative analysis of blood-borne 18F-FMISO metabolites in cancer patients by HPLC using an integrated high-sensitivity coincidence detector
  • Longitudinal Analysis of Bone Metabolism Using SPECT/CT and Tc-99m-Diphosphono-Propanedicarboxylic Acid: Comparison of Visual and Quantitative Analysis
  • 188Re-microspheres for selective intra-arterial radionuclide therapy (SIRT) in patients with HCC: Feasibility study
Show more Oncology: Basic, Translational & Therapy

MTA I: Radiopharmaceutical Therapy Posters

  • Chinese data of efficacy of low- and high-dose of iodine-131 for the ablation of thyroid remnant
  • Anlysis of clinical factors related with successful ablation following rhTSH aided radioiodine ablation for well differentiated thyroid cancer.
  • 211At-Labeled Small-Molecule PSMA Inhibitors: Effect of Structure on Biodistribution in Mice
Show more MTA I: Radiopharmaceutical Therapy Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire